Cost/benefit analysis of aminoglycoside use without a kinetic dosing service.
D000328:Adult; D000368:Aged; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000097:blood*; D003362:Cost-Benefit Analysis; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000191:economics*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents